DEVELOPMENT AND MANUFACTURE OF MICROBIAL-DERIVED BIOPHARMACEUTICALS

Richter-Helm is a leading and steadily growing biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with two cGMP-compliant manufacturing facilities in Germany.

We specialize in products derived from bacteria and yeasts. Over the past 30 years we gained substantial experience in the development and manufacture of product types that include recombinant proteins and peptides, antibody-like scaffolds (VHH/ Nanobodies, Fab fragments), plasmid DNA, and bacterial vaccines.

Play Video

We move our clients projects forward: flexible, transparent, fast

GMP production expert in lab clothing with production plant in the background

Our Expertise

PROCESS DEVELOPMENT

CUSTOMIZED

ANALYTICS

RELIABLE

PRODUCTION

FLEXIBLE

QUALITY

APPROVED

PROCESS DEVELOPMENT

CUSTOMIZED

ANALYTICS

RELIABLE

PRODUCTION

FLEXIBLE

QUALITY

APPROVED

Our Microbial Capabilities

Our company in numbers

+ 0
Employees at three facilities
0
max fermenter volume at Hannover
0
max fermenter volume at Bovenau
0
m² of total production area

How Richter-Helm Overcomes the Challenges of the Covid-19 Pandemic

Latest News

Biotechnologische Produktion ist unsere DNA

CORONA WAR EIN BOOSTER FÜR DIE BIOTECHNOLOGIE-BRANCHE.
Die Richter-Helm Biologics GmbH & Co. KG aus Hamburg ist seit über 30 Jahren ein Lohnhersteller für biopharmazeutische Produkte. Mit großer Expertise im Bereich der DNA-Impfstoffe war das Unternehmen während der Pandemie für große US Entwicklungsunternehmen ein wichtiger Produktionspartner.
Mit neuen Produktionsanlagen will das Unternehmen jetzt seine Kapazitäten für die kommenden Jahre weiter ausbauen.

read more

A guide to the analysis of plasmid DNA

Plasmids are circular, double-stranded DNA molecules of various sizes originally found in bacteria, archaea and eukaryotic yeast. They replicate independently of chromosomal DNA and are easily genetically modified. Plasmids can be used for a variety of pharmaceutical purposes: as the active pharmaceutical ingredient (API) in DNA vaccines to prevent viral infections or cancer development; as critical raw material, starting material or ancillary material for viral vector production; or as template for mRNA-based products.

read more

Delivering flexible and transparent manufacturing processes

Developing and manufacturing microbial-derived biopharmaceutical products require deep expertise and reliable solutions that can guide a project to success while meeting evolving industry standards. To this end, pharmaceutical companies need expert partners capable of bringing promising cures to the market on time, regardless of scale.

read more

Leveraging Experience To Support Biologics Manufacturingfrom Gene to Product

In recent years, customer requirements for contract development and manufacturing organization (CDMO) services have changed. CDMOs have developed into partners, consultants, and providers of specific services, all preferably coming from a single source. Richter-Helm is one driver of a transparent, flexible, guided, and solution-oriented way of partnership, offering its clients a full-service approach along the entire journey from gene to finished product.

read more